OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cannabidiol‐associated hepatotoxicity: A systematic review and meta‐analysis
Lindsay A. Lo, April Christiansen, Lauren Eadie, et al.
Journal of Internal Medicine (2023) Vol. 293, Iss. 6, pp. 724-752
Open Access | Times Cited: 35
Lindsay A. Lo, April Christiansen, Lauren Eadie, et al.
Journal of Internal Medicine (2023) Vol. 293, Iss. 6, pp. 724-752
Open Access | Times Cited: 35
Showing 1-25 of 35 citing articles:
Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline
Ilana M. Braun, Kari Bohlke, Donald I. Abrams, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 13, pp. 1575-1593
Closed Access | Times Cited: 20
Ilana M. Braun, Kari Bohlke, Donald I. Abrams, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 13, pp. 1575-1593
Closed Access | Times Cited: 20
Metabolism and liver toxicity of cannabidiol
Si Chen, Yuxi Li, Xilin Li, et al.
Journal of Environmental Science and Health Part C (2024) Vol. 42, Iss. 3, pp. 238-254
Open Access | Times Cited: 11
Si Chen, Yuxi Li, Xilin Li, et al.
Journal of Environmental Science and Health Part C (2024) Vol. 42, Iss. 3, pp. 238-254
Open Access | Times Cited: 11
Cannabis for Chronic Pain: Mechanistic Insights and Therapeutic Challenges
Carla Matos, Ana Teresa Pereira, Maria João Dias, et al.
Stresses (2025) Vol. 5, Iss. 1, pp. 7-7
Open Access | Times Cited: 1
Carla Matos, Ana Teresa Pereira, Maria João Dias, et al.
Stresses (2025) Vol. 5, Iss. 1, pp. 7-7
Open Access | Times Cited: 1
Is the potential for bioaccumulation of cannabinoids underestimated? Insights from biomimetic chromatography in cannabinoid exposure evaluation
Krzesimir Ciura, Kamila Jarzyńska, Katarzyna Ewa Greber, et al.
Food and Chemical Toxicology (2025), pp. 115252-115252
Closed Access | Times Cited: 1
Krzesimir Ciura, Kamila Jarzyńska, Katarzyna Ewa Greber, et al.
Food and Chemical Toxicology (2025), pp. 115252-115252
Closed Access | Times Cited: 1
Advances and Challenges in Modeling Cannabidiol Pharmacokinetics and Hepatotoxicity
Jessica L. Beers, Zhu Zhou, Klarissa D. Jackson
Drug Metabolism and Disposition (2024) Vol. 52, Iss. 6, pp. 508-515
Open Access | Times Cited: 6
Jessica L. Beers, Zhu Zhou, Klarissa D. Jackson
Drug Metabolism and Disposition (2024) Vol. 52, Iss. 6, pp. 508-515
Open Access | Times Cited: 6
Comparison on the mechanism and potency of hepatotoxicity among hemp extract and its four major constituent cannabinoids
Xiugong Gao, Kayla Campasino, Miranda R. Yourick, et al.
Toxicology (2024) Vol. 506, pp. 153885-153885
Open Access | Times Cited: 5
Xiugong Gao, Kayla Campasino, Miranda R. Yourick, et al.
Toxicology (2024) Vol. 506, pp. 153885-153885
Open Access | Times Cited: 5
Cannabidiol (CBD) Products for Pain: Ineffective, Expensive, and With Potential Harms
Andrew Moore, Sebastian Straube, Emma Fisher, et al.
Journal of Pain (2023) Vol. 25, Iss. 4, pp. 833-842
Open Access | Times Cited: 11
Andrew Moore, Sebastian Straube, Emma Fisher, et al.
Journal of Pain (2023) Vol. 25, Iss. 4, pp. 833-842
Open Access | Times Cited: 11
Exploring the safety of cannabidiol (CBD): A comprehensive in vitro evaluation of the genotoxic and mutagenic potential of a CBD isolate and extract from Cannabis sativa L
Alja Štern, Matjaž Novak, Katja Kološa, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116969-116969
Open Access | Times Cited: 4
Alja Štern, Matjaž Novak, Katja Kološa, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116969-116969
Open Access | Times Cited: 4
Effects of maternal edible THC consumption on offspring lung growth and function in a rhesus macaque model
Lyndsey E. Shorey‐Kendrick, Adam Crosland, Matthias C. Schabel, et al.
AJP Lung Cellular and Molecular Physiology (2025) Vol. 328, Iss. 3, pp. L463-L477
Closed Access
Lyndsey E. Shorey‐Kendrick, Adam Crosland, Matthias C. Schabel, et al.
AJP Lung Cellular and Molecular Physiology (2025) Vol. 328, Iss. 3, pp. L463-L477
Closed Access
Medicinal CANnabis (CBD/THC) to prevent the symptoms and side effects of chemotherapy in people with advanced CANcer (CANCAN): protocol for a phase II, randomised, double-blind, placebo-controlled trial
Olivia Bellas, Katrina Cao, Joanne M. Bowen, et al.
BMJ Open (2025) Vol. 15, Iss. 3, pp. e089336-e089336
Open Access
Olivia Bellas, Katrina Cao, Joanne M. Bowen, et al.
BMJ Open (2025) Vol. 15, Iss. 3, pp. e089336-e089336
Open Access
Pharmacokinetics of cannabidiol, (-)-trans-Δ9-tetrahydrocannabinol, and their oxidative metabolites after intravenous and oral administration of a cannabidiol-dominant full-spectrum hemp product to beagle dogs
Susanna E. Kitts-Morgan, Richard A. Sams, William W. Muir
Frontiers in Veterinary Science (2025) Vol. 12
Open Access
Susanna E. Kitts-Morgan, Richard A. Sams, William W. Muir
Frontiers in Veterinary Science (2025) Vol. 12
Open Access
Effects of five cannabis oils with different CBD:THC ratios and terpenes on hypertension, dyslipidemia, hepatic steatosis, oxidative stress, and CB1 receptor in an experimental model
Valentina Degrave, Michelle Berenice Vega Joubert, Camila Fillipa, et al.
Research Square (Research Square) (2025)
Closed Access
Valentina Degrave, Michelle Berenice Vega Joubert, Camila Fillipa, et al.
Research Square (Research Square) (2025)
Closed Access
The role of cannabidiol in aging
Beibei Ni, Yanying Liu, Meng Dai, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115074-115074
Open Access | Times Cited: 10
Beibei Ni, Yanying Liu, Meng Dai, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115074-115074
Open Access | Times Cited: 10
Investigation of cannabidiol-induced cytotoxicity in human hepatic cells
Si Chen, Xilin Li, Qiangen Wu, et al.
Toxicology (2024) Vol. 506, pp. 153884-153884
Closed Access | Times Cited: 3
Si Chen, Xilin Li, Qiangen Wu, et al.
Toxicology (2024) Vol. 506, pp. 153884-153884
Closed Access | Times Cited: 3
Therapeutic potentials of cannabidiol: Focus on the Nrf2 signaling pathway
Marjan Talebi, Mohammad Mehdi Sadoughi, Seyed Abdulmajid Ayatollahi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115805-115805
Open Access | Times Cited: 8
Marjan Talebi, Mohammad Mehdi Sadoughi, Seyed Abdulmajid Ayatollahi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115805-115805
Open Access | Times Cited: 8
Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?
Dirk W. Lachenmeier, Stephanie Habel, Berit Fischer, et al.
F1000Research (2023) Vol. 8, pp. 1394-1394
Open Access | Times Cited: 7
Dirk W. Lachenmeier, Stephanie Habel, Berit Fischer, et al.
F1000Research (2023) Vol. 8, pp. 1394-1394
Open Access | Times Cited: 7
Human Data on Pharmacokinetic Interactions of Cannabinoids: A Narrative Review
Cecilia Maldonado, Raquel Peyraube, Pietro Fagiolino, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 4, pp. 241-254
Closed Access | Times Cited: 2
Cecilia Maldonado, Raquel Peyraube, Pietro Fagiolino, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 4, pp. 241-254
Closed Access | Times Cited: 2
Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline Q&A
Ilana M. Braun, Kari Bohlke, Eric Roeland
JCO Oncology Practice (2024) Vol. 20, Iss. 6, pp. 767-770
Closed Access | Times Cited: 2
Ilana M. Braun, Kari Bohlke, Eric Roeland
JCO Oncology Practice (2024) Vol. 20, Iss. 6, pp. 767-770
Closed Access | Times Cited: 2
The effects of cannabinoids on the kidney
Steven Didik, Oleg Palygin, Mark Chandy, et al.
Acta Physiologica (2024) Vol. 240, Iss. 12
Open Access | Times Cited: 2
Steven Didik, Oleg Palygin, Mark Chandy, et al.
Acta Physiologica (2024) Vol. 240, Iss. 12
Open Access | Times Cited: 2
Cannabigerol (CBG): A Comprehensive Review of Its Molecular Mechanisms and Therapeutic Potential
Shijia Li, Weini Li, Naseeb Kaur Malhi, et al.
Molecules (2024) Vol. 29, Iss. 22, pp. 5471-5471
Open Access | Times Cited: 2
Shijia Li, Weini Li, Naseeb Kaur Malhi, et al.
Molecules (2024) Vol. 29, Iss. 22, pp. 5471-5471
Open Access | Times Cited: 2
Cannabidiol safety considerations: Development of a potential acceptable daily intake value and recommended upper intake limits for dietary supplement use
Rayetta G. Henderson, Melissa Vincent, Brianna N. Rivera, et al.
Regulatory Toxicology and Pharmacology (2023) Vol. 144, pp. 105482-105482
Open Access | Times Cited: 5
Rayetta G. Henderson, Melissa Vincent, Brianna N. Rivera, et al.
Regulatory Toxicology and Pharmacology (2023) Vol. 144, pp. 105482-105482
Open Access | Times Cited: 5
The Main Therapeutic Applications of Cannabidiol (CBD) and Its Potential Effects on Aging with Respect to Alzheimer’s Disease
Václav Trojan, Leoš Landa, Alexandra Šulcová, et al.
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1446-1446
Open Access | Times Cited: 4
Václav Trojan, Leoš Landa, Alexandra Šulcová, et al.
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1446-1446
Open Access | Times Cited: 4
Human quad liver-on-chip system as a tool toward bridging the gap between animals and humans regarding toxicology and pharmacology of a cannabidiol-rich cannabis extract
Laura Ewing, Charles M. Skinner, Mitchell R. McGill, et al.
Drug and Chemical Toxicology (2024), pp. 1-8
Closed Access | Times Cited: 1
Laura Ewing, Charles M. Skinner, Mitchell R. McGill, et al.
Drug and Chemical Toxicology (2024), pp. 1-8
Closed Access | Times Cited: 1
Clinical guidance for cannabidiol‐associated hepatotoxicity: A narrative review
Lauren Eadie, Lindsay A. Lo, Michael Boivin, et al.
Journal of Gastroenterology and Hepatology (2024)
Open Access | Times Cited: 1
Lauren Eadie, Lindsay A. Lo, Michael Boivin, et al.
Journal of Gastroenterology and Hepatology (2024)
Open Access | Times Cited: 1
An overview of major depression disorder: The endocannabinoid system as a potential target for therapy
Sergio Zarazúa, Jorge Genaro Vicente‐Martínez, Juan Manuel Pinos‐Rodríguez, et al.
Basic & Clinical Pharmacology & Toxicology (2024)
Open Access | Times Cited: 1
Sergio Zarazúa, Jorge Genaro Vicente‐Martínez, Juan Manuel Pinos‐Rodríguez, et al.
Basic & Clinical Pharmacology & Toxicology (2024)
Open Access | Times Cited: 1
